Stock Split History
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| PDSB Stock Split History |
| Preferred Stock Newsletter |
| PDSB Options Chain |
| Stock Message Boards |
PDS Biotechnology (PDSB) has 1 split in our PDS Biotechnology stock split history database. The split for PDSB took place on March 18, 2019. This was a 1 for 20 reverse split, meaning for each 20 shares of PDSB owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 50 share position following the split.
When a company such as PDS Biotechnology conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the PDS Biotechnology stock split history from start to finish, an original position size of 1000 shares would have turned into 50 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PDS Biotechnology shares, starting with a $10,000 purchase of PDSB, presented on a split-history-adjusted basis factoring in the complete PDS Biotechnology stock split history.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 10/01/2015 | |
| End date: | 05/02/2024 | |
| Start price/share: | $258.80 | |
| End price/share: | $3.73 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -98.56% | |
| Average Annual Total Return: | -38.95% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $144.10 | |
| Years: | 8.59 | |
 |
| About PDS Biotechnology |
| PDS Biotechnology is an immunotherapy company developing molecularly targeted immunotherapies designed to overcome the limitations of existing immunotherapy and vaccine technologies. Co.'s T cell activating platforms designed to train the immune system to attack and destroy disease; Versamune®, and Versamune plus PDS0301 for treatments in oncology; and Infectimune, for treatments in infectious disease. Co. develops targeted product candidates to treat several cancers including Human Papillomavirus-associated cancers, melanoma, colorectal, lung, breast and prostate cancers. Co.'s infectious disease candidates are of potential interest for use in COVID-19 and universal influenza vaccines. According to our PDS Biotechnology stock split history records, PDS Biotechnology has had 1 split. |
| PDSB Split History Table | |
| Date | Ratio |
| 03/18/2019 | 1 for 20 |
| Healthcare Stock Splits |
| PDSB is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
PFE Split History Also explore: PDSB shares outstanding history
|
Free PDSB Email Alerts:
PDS Biotechnology Stock Split History | www.StockSplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.StockSplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.